Changing strategies in the management of asthma.
Mortality from asthma is apparently on the rise and, in some cases, may be due to the type and amount of medication used by the patient. As a result, the role of some commonly prescribed agents has changed in recent years. In this article, the authors review modifications in the use of currently available drugs, discuss new applications of drugs not traditionally used for asthma, and examine the rationale behind the development of entirely new classes of drugs.
Gianaris
P G
PG
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195.
Golish
J A
JA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D020024:Leukotriene Antagonists; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D020024:Leukotriene Antagonists; D013806:Theophylline